31: The Medicine Box: Kiran Mazumdar-Shaw on biosimilar interchangeable status for Biocon's diabetes drug

The Medicine Box ›

15:21 | Nov 25th, 2021

In a significant development this year, the United States Food and Drug Administration granted interchangeable status to two biosimilar drugs— Biocon's diabetes drug insulin glargine branded as Semgle...Show More